Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6322412
Reference Type
Journal Article
Title
A PLAIN-LANGUAGE SUMMARY OF THE SOLAR-1 TRIAL: STUDYING ALPELISIB WITH FULVESTRANT IN PATIENTS WITH HR+, HER2-ADVANCED BREAST CANCER WHO HAD PREVIOUSLY RECEIVED AN AROMATASE INHIBITOR
Author(s)
Aubel, D; Loibl, S; Kaufman, B; Lu, YenS; Juric, D; Mayer, I; Ciruelos, Eva; Campone, M; Conte, P; Iwata, H; Rugo, H; Ghaznawi, F; Gillis, K; Mills, D; Andre, F
Year
2019
Is Peer Reviewed?
1
Journal
The Breast
ISSN:
0960-9776
Publisher
Elsevier
Volume
48
Issue
Elsevier
Page Numbers
S48-S48
DOI
10.1016/S0960-9776(19)30680-0
Web of Science Id
WOS:000502083600067
URL
https://linkinghub.elsevier.com/retrieve/pii/S0960977619306800
Exit
Tags
PFAS
•
Additional PFAS (formerly XAgency)
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity